PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation-Reference-Cited by-同舟云学术

PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation

Published:2022-11 Issue: Volume:37 Page:130-136
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Murray Julia^ORCID,Cruickshank Clare,Bird Thomas^ORCID,Bell Philip,Braun John,Chuter Dave^ORCID,Ferreira Miguel Reis,Griffin Clare,Hassan Shama,Hujairi Nabil,Melcher Alan,Miles Elizabeth^ORCID,Naismith Olivia,Panades Miguel,Philipps Lara^ORCID,Reid Alison,Rekowski Jan^ORCID,Sankey Pete,Staffurth John,Syndikus Isabel^ORCID,Tree Alison,Wilkins Anna,Hall Emma

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference24 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries Hyuna Sung PhD CA: A Cancer Journal for Clinicians Volume 71, issue 3 pages 209-249.

2. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019;Wang;Front Public Health,2022

3. https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/ (accessed 7th September 2022).

4. STAMPEDE investigators. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multi-arm, multistage, platform randomised controlled trial;James;Lancet,2016

5. James ND, de Bono JS, Spears MR, Clarke NW, Mason MD, et al. STAMPEDE investigators. abiraterone for prostate cancer not previously treated with hormone therapy. N Engl J Med 2017 Jul 27;377(4):338-351.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pushing the Borders: One at a Time. Reply to C. Onal, A. Elmaliy, P. Hurmuz's Letter to Editor Re: Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines in Regard to Singh et al.;Clinical Oncology;2024-09

2. Prognostic impact of prostate‐specific membrane antigen positron emission tomography (PSMA PET) staging for clinically node‐positive prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-04-15

3. How High Should We Go for Para-aortic Lymph Node Radiation Therapy?;International Journal of Radiation Oncology*Biology*Physics;2023-11

4. Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography;International Journal of Radiation Oncology*Biology*Physics;2023-11

5. Comment on “Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients”;British Journal of Cancer;2023-01-30